Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Adial Pharmaceuticals Inc
(NQ:
ADIL
)
2.390
USD
UNCHANGED
Streaming Delayed Price
Updated: 7:46 PM EST, Mar 1, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
2.390
Bid (Size)
2.310 (1)
Ask (Size)
2.390 (8)
Prev. Close
2.390
Today's Range
2.390 - 2.390
52wk Range
1.000 - 4.000
Shares Outstanding
5,474,856
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Adial Schedules Town Hall to Discuss Positive Updates Regarding Pharmaceutical Pipeline and Business Expansion
February 26, 2021
From
GlobeNewswire News Releases
Adial Receives $1.425 Million in Net Proceeds from Exercise of Warrants
February 26, 2021
From
GlobeNewswire News Releases
Performance
YTD
+38.15%
+38.15%
1 Month
+11.16%
+11.16%
3 Month
+2.58%
+2.58%
6 Month
+73.19%
+73.19%
1 Year
+69.50%
+69.50%
More News
Read More
Adial Pharmaceuticals Achieves 50% Enrollment in ONWARD™ Phase 3 Trial
February 25, 2021
From
GlobeNewswire News Releases
Adial to File Fast Track Application for AD04 with the FDA
February 23, 2021
From
GlobeNewswire News Releases
Adial Pharmaceuticals Closes Acquisition of Purnovate
January 26, 2021
From
ACCESSWIRE
Adial Pharmaceuticals to Present at 23rd Annual ICR Conference
January 11, 2021
From
ACCESSWIRE
Adial Pharmaceuticals Receives Notice of Allowance for Third U.S. Patent Covering AD04 for the Treatment for Opioid Use Disorder
January 11, 2021
From
ACCESSWIRE
Adial Pharmaceuticals Appoints Dr. Jack Reich as Head of Regulatory
December 15, 2020
From
ACCESSWIRE
Adial Pharmaceuticals Schedules Business Update Conference Call to Discuss Planned Acquisition of Purnovate and other Recent Developments
December 10, 2020
From
ACCESSWIRE
Adial Pharmaceuticals Enters Agreement to Acquire Purnovate, a Developer of Potential Therapies for Non-Opioid Pain Reduction and Treatment of Addiction
December 10, 2020
From
ACCESSWIRE
BioMedNewsBreaks – Adial Pharmaceuticals Inc (NASDAQ: ADIL) Featured by M-Vest
February 05, 2021
From
InvestorBrandNetwork
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.